Page last updated: 2024-10-22

anastrozole and Dermatomyositis

anastrozole has been researched along with Dermatomyositis in 1 studies

Dermatomyositis: A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)

Research Excerpts

ExcerptRelevanceReference
"When tamoxifen therapy was discontinued after 4 years of use in the first patient, her DM rash worsened and remained difficult to control with conventional immunosuppressant medication."1.33Improvement in dermatomyositis rash associated with the use of antiestrogen medication. ( Sereda, D; Werth, VP, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sereda, D1
Werth, VP1

Other Studies

1 other study available for anastrozole and Dermatomyositis

ArticleYear
Improvement in dermatomyositis rash associated with the use of antiestrogen medication.
    Archives of dermatology, 2006, Volume: 142, Issue:1

    Topics: Adult; Anastrozole; Biopsy; Breast Neoplasms; Dermatomyositis; Diagnosis, Differential; Estrogen Ant

2006